Scribe Therapeutics Inc.

Alameda, CA

UEI
E9LNGD3EP3H8
CAGE
82F75
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
1150 Marina Village Pkwy, Alameda, CA 94501, USA
Website
scribetx.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Genome editing using a novel crispr protein R43GM131532 National Institute of General Medical Sciences (NIH) -$149,850
Development of crispr-CAS guiderna screening platform for allele-specific reduction of mutant huntingtin protein R43NS110161 National Institute of Neurological Disorders and Stroke (NIH) -$299,700

Quick answers

Is Scribe Therapeutics Inc. registered in SAM.gov?

Yes. Scribe Therapeutics Inc.'s SAM.gov registration is active through June 10, 2027.

What is Scribe Therapeutics Inc.'s most recent federal award?

Scribe Therapeutics Inc.'s most recent federal grant award is Genome editing using a novel crispr protein (R43GM131532), from National Institute of General Medical Sciences (NIH), on June 1, 2019.

On GovTribe

See Scribe Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login